Overview

Effect of EPA-FFA on Polypectomy in Familial Adenomatous Polyposis

Status:
Recruiting
Trial end date:
2024-01-01
Target enrollment:
Participant gender:
Summary
2 Year randomised, double-blind, placebo-controlled, parallel group study to determine the safety and efficacy of EPA-FFA gastro resistant capsules in FAP.
Phase:
Phase 3
Details
Lead Sponsor:
S.L.A. Pharma AG